A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression
Sponsor: Jieqiong Cui
This EARLY_PHASE1 trial investigates Depressive Disorder and Mental Disorder in Adolescence and is currently ongoing. Jieqiong Cui leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
6 versions recorded-
Nov 2024 — Present [monthly]
Unknown EARLY_PHASE1
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Nov 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Nov 2022 — Jul 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting EARLY_PHASE1
▶ Show 1 earlier version
-
Mar 2022 — Sep 2022 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Jieqiong Cui
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.